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Abstract
Background: Diabetes is rising in prevalence; painful diabetic neuropathy (PDN) is one 
complication of diabetes. PDN is primarily managed with medication but analgesic failure 
is common and people remain in pain and distress. It is unclear whether pain 
management strategies are appropriate for PDN. 
Objectives: To establish the effectiveness of physical activity and psychological coping 
strategies for PDN. 
Design: Systematic literature review.
Data sources: Ten online databases.
Eligibility criteria (participants and interventions): Controlled trials reporting specific 
results for PDN, investigating, (a) physical activity or (b) psychological coping strategies 
and measuring pain as an outcome.  The search was restricted to published research with 
no restriction on language or date of publication.
Study appraisal methods: Methodological quality and risk of bias assessed with Cochrane 
Collaboration and NICE checklist for randomised controlled trials.
Results: Of 1306 titles identified, four studies met the inclusion criteria. Two trials 
investigated physical activity and two investigated psychological coping interventions. 
Studies showed pain measures improved or did not worsen compared to controls, but 
methodological quality was moderate and results need cautious interpretation.
Limitations: The studies were of small sample size and used a diverse range of outcome 
measures. There is high risk of bias from lack of blinding and attrition at follow up. 
Conclusions and implications of key findings: The research literature in this area is sparse 
and inconsistent, despite the pressing clinical challenge of PDN. Firm conclusions cannot 
be drawn from the studies included. Further high quality research is required to match 
treatment provision to patient requirements. 
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Introduction
Diabetes Mellitus (DM) is an increasingly common endocrine disorder, the 
prevalence of which is rising due to rising levels of obesity, decreasing physical activity 
and an ageing population [1]. As management strategies for DM have improved there has 
been a decrease in the mortality due to DM, and an increase in the morbidity associated 
with potential complications [2,3]. Diabetes has been highlighted as the ninth leading 
cause of years lived with disability [4].
Painful diabetic neuropathy (PDN) is a significant complication of DM and is thought 
to be caused, at least in part, by pathological microvascular changes to the small nerve 
fibres particularly within the feet and hands [5]. These changes lead to a burning pain in a 
‘glove and stocking’ distribution that is spontaneous and unpredictable; the pain is not 
related to physical activity and is often worse at night [6]. PDN is linked with significant 
impact on physical function and mobility [7] and is associated with negative effect on 
mood state and quality of life over and above the impact of diabetes alone [8]. PDN 
affects 16-23% of people with DM [9,10], that is, approximately 600,000 people in the UK.
The management of PDN is primarily pharmacological and there are published 
guidelines for the medical management of neuropathic pain in general [11,12] and of PDN 
specifically [13,14]. However, these recommendations do not always agree, which leads 
to clinical uncertainty [15]  compounded by the fact that successful pharmacological 
management is achieved in less than half of patients with PDN [16]. The recent National 
Institute for Health and Care Excellence (NICE) update [12] has removed specific advice 
on which medications should be considered first line therapy. 
Multidisciplinary pain management programmes have an established evidence base
for management of other persistent pain conditions [17–19]. Programmes incorporate 
various forms of physical activity and a range of psychological models (for example 
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Cognitive Behavioural Therapy (CBT) or Acceptance and Commitment Therapy), but have 
physical reactivation and psychological coping as their key tenets [20].
In the context of pain management, physical activity is not aimed at curing the pain 
problem but at increasing the person’s ability to cope [20]. The physical aspect aims to
help people establish a baseline for functional movements and use principles of graded 
exposure and pacing [21] to gradually increase levels of physical capacity. A recent study 
[22] of people with PDN (n=2576) identified ‘general activity’ and ‘walking ability’ as the 
most important functions to be improved through treatment of their PDN. These patient 
expectations are well within the remit of physiotherapy, but there is a lack of evidence for 
any specific form of physical activity in the management of PDN.
Psychological coping includes the use of cognitive and behavioural interventions to 
help people challenge maladaptive thoughts in order to manage a persistent pain 
problem. The use of these strategies specifically for the management of neuropathic pain, 
have been examined in a previous systematic review [27].  No firm conclusions were 
possible and it was subsequently criticised for the breadth of interventions (CBT, hypnosis, 
cognitive restructuring etc.) and pathologies (Phantom limb pain, Spinal cord injury etc.) 
that were included in the selection process [28].
It may appear plausible to transfer effective management strategies for 
musculoskeletal pain, to the population who experience neuropathic pain. However, it 
has been suggested inappropriate to consider all people with persistent pain as a 
homogenous population, and that greater efforts to target specific treatments to 
particular sub-groups are required [23,24]. One sub-grouping would be the proposed 
dominant pain mechanism. Daniel et al. [25] highlighted differences between people with 
predominantly nociceptive versus neuropathic pain. They found pain-aggravating factors 
differed, with neuropathic pain greater influenced by environmental temperature and life 
stress. They found participant beliefs about causes and pain mechanisms differed, with 
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neuropathic pain seen as due to nerve damage from a disease process. Martin et al. [26]
investigated patient understanding of neuropathic pain and highlighted a number of 
factors relevant to pain rehabilitation: the patient accepting the presence (or not) of 
psychological influences on pain and the acceptability (or not) of psychologically based 
treatment options. These data and those of Daniel et al. [25], suggest participant beliefs 
about aggravating factors, causes and mechanisms of pain may need to be taken into 
account in a manner specific to neuropathic pain, when designing therapeutic 
interventions.
Physiotherapists are increasingly expected to deliver a blend of physical 
rehabilitation and psychological pain coping strategies, as psychologically informed 
physiotherapy [17]. Around 50% of people who experience PDN have other 
musculoskeletal causes of pain, which may bring them into contact with physiotherapists 
[22]. Furthermore, as the prevalence of diabetes and PDN increase, patients in 
physiotherapy are increasingly likely to have PDN either as a co-morbidity, or potentially 
as a reason for referral. Guidance documents for PDN recommend specialist assessment 
when pharmacology fails [12], but do not detail what this assessment and potential 
treatment should consist of.
The physical and psychological coping strategies taught within existing pain 
management programmes may be appropriate for helping patients to manage the 
persistent pain of PDN, however the evidence base for these are unknown. 
Objectives.
This systematic review had three objectives: to establish the evidence for 1) 
physical activity and 2) psychological coping strategies, in the management of PDN; and 3) 
identify gaps in evidence to inform future research priorities in the management of PDN.
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Methods
Protocol and registration
The review protocol was registered with PROSPERO (CRD42013006365) [27], and is 
reported in accordance with PRISMA recommendations [28].
Eligibility criteria
Studies were required to meet the following inclusion criteria: (1) a study 
population with clear diagnosis of painful neuropathy, secondary to diabetes (PDN) and 
results reported specifically for PDN, where other neuropathic pain pathologies were 
included in the trial; (2) human subjects, 18yrs+; (3) intervention that was either a) 
physical activity or b) therapeutic interventions delivered under an overarching 
psychological framework; (4) pain outcome measures (5) controlled methodology; (6) 
original peer-reviewed research. No exclusion was made based upon language or date of 
publication.
Information sources
Ten electronic databases were searched: the Cochrane Library, Physiotherapy 
Evidence Database (PEDro), Medline, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Allied and Complementary Medicine (AMED), Embase, SportDiscus, 
Web of Science, BioMed Central and PsychINFO.
Search
To ensure a specific and sensitive search strategy was developed, existing high 
quality reviews, published by Cochrane and known to the authors, were initially scoped 
for physical activity search terms [29,30].  These terms were further developed to 
incorporate terms for physical activity targeting neural tissue, as this form of activity may 
have direct relevance to the population with PDN. This review uses the term 
psychological coping to include any strategy used in pain management programmes that 
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aims to help the patient live with persistent pain. Existing systematic reviews of cognitive,
behavioural and acceptance based psychological interventions were used as the basis for 
developing psychological coping search terms [19,29]. The full search strategy can be 
found in supplementary information Table 1. 
This search was applied via EBSCO to Medline, AMED, EMBASE, CINAHL, 
SportDiscus and PsychINFO. A simplified search strategy was used for PEDro, Cochrane 
Library, BioMed Central and Web of Science. These searches were conducted (by B.D.) in 
the week beginning 18th November 2013 and repeated 2nd July 2014 to ensure the results 
were up-to-date.
Study selection
From the studies retrieved, duplicates were removed and the titles judged against 
the eligibility criteria. Studies that clearly did not meet eligibility criteria were excluded. 
Abstracts for all remaining studies were then reviewed and judged against the eligibility 
criteria. The full texts of studies that could not be clearly excluded were obtained. These 
full texts were judged against eligibility criteria to select the final included studies. In the 
case of uncertainty, discussions were had within the research team to reach a consensus, 
and authors were contacted for additional information where this was appropriate.
Data collection process and data items
The principal data extracted from the selected studies included: evidence of 
diagnostic criteria for PDN, nature of intervention (type of physical activity, type of 
psychological coping therapy), demographics of the control and intervention arm, 
duration of follow up, pain outcome measures and, if available, quality of life measures as 
secondary outcomes, results, attrition rates and noted adverse effects. Prior to 
commencing the review, scoping of the literature, indicated that relevant studies 
investigating physical activity and psychological coping strategies incorporated a broad 
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range of complex heterogeneous interventions.  On this basis it was decided ‘a priori’,
that quantitative synthesis of study results would be inappropriate, rather a narrative 
synthesis would be presented to outline preliminary size and direction of intervention 
effects [30].
Critical Appraisal and Risk of bias in individual studies
Risk of bias was assessed using the Cochrane Collaboration tool [31] and 
methodological quality was further assessed using the NICE critical appraisal tool for 
randomised studies [32]. This process ensured that each study was assessed consistently, 
which limited reviewer bias in the assessment of quality. The lead author conducted this 
process and a second review was performed by FC for studies involving physical activity 
and by JGG for studies involving psychological interventions. The individual appraisals 
were discussed and a consensus reached.
Results
Study selection
After duplicates were removed, 1306 potential studies remained. After 
consideration against the eligibility criteria four articles were retained for full review, two 
studies focused on physical activity and two focused on psychological interventions. The 
outline of the screening process is summarised in Figure A – Study selection. 
Study characteristics (see Table 2)
One quasi-experimental trial of Tai Chi [33] and one randomised controlled trial 
investigating aerobic physical exercise [34] were selected. There were two randomised 
controlled trials of psychological interventions, CBT and Mindfulness relaxation [35,36]. 
Studies included participants diagnosed with Type 1 and Type 2 diabetes, although the 
majority had Type 2. Sample sizes ranged from 19-87, with only two studies reporting a 
sample size calculation [33,36]. The intervention arms were compared with treatment as 
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usual [33–35] or a control arm of diabetes self-care education providing equivalent 
contact time with a health professional as the intervention arm [36]. 
Risk of bias and quality appraisal
A summary of the Cochrane bias appraisal can be found in Table 3, the NICE 
checklist is available in the supplementary information Table 4.
Two studies of physical activity met the eligibility criteria.  Ahn et al. [33] conducted 
a quasi-experimental study investigating the effects of Tai Chi. Tai Chi had previously 
been shown to increase peripheral vasodilation and have a potential beneficial effect on 
HbA1c levels (a measure of blood glucose control) [33]. The first thirty participants 
consented were allocated Tai Chi, and their outcomes compared to the next block of 
twenty-nine control participants. A sample size calculation was conducted based on the 
ability to detect change in HbA1c, and the target sample was recruited. Although not true 
randomisation there were no significant differences between study arms at baseline. The 
authors used a robust range of outcome measures but they did not state if the assessors 
were blind to treatment allocation. The study suffered from a high drop-out rate (~30%) 
in both study arms and the management of missing data was not discussed, so results are 
at risk of attrition bias. 
One study investigated structured aerobic exercise. Dixit et al. [34] stratified the 
severity of the neuropathy using the Michigan Diabetic Neuropathy Score and then 
randomised participants into study arms. There were clear protocols for minimising 
allocation and detection bias, through blinding of researchers to the trial arm of 
participants. Anthropometrics were shown to be similar between trial arms at baseline, 
but other characteristics were not analysed. Clear details of the intervention were 
provided, and the control arm received weekly physician appointments. Such frequency 
may not represent true ‘treatment as usual’. No sample size calculation was conducted, 
however the researchers assessed 335 potential participants and recruited only 87, 
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suggesting difficulties in recruitment from their population. There was significant loss to 
follow up (~22%) in both arms of the trial, no details were provided of how missing data 
were managed so the results are at risk of attrition bias. 
Two studies met the criteria for psychological coping strategies. Otis et al. [35]
conducted a pilot trial of CBT in a US military veterans population. The CBT programme 
reflected the curriculum of pain management programmes as advised by the British Pain 
Society [20]. Participants were randomised to a trial arm and the arms were 
demonstrated to be comparable at baseline. The CBT intervention was clearly outlined
and was compared against usual treatment within primary care. The study used the West 
Haven Yale Multidimensional Pain Inventory as their primary outcome measure, which 
has not been validated for neuropathic pain. It was not clear that outcome assessors 
were fully blind to the treatment arm. The authors took repeated measures (pre-, post-
course and at four months), and used appropriate statistical analysis to account for 
repeated measures (Hierarchical Linear Model), but caution should be applied due to the 
small sample size (n=19) and high attrition in the treatment arm (3 of 11, 27%).
Teixeira [36] studied the effect of mindfulness relaxation on PDN. Mindfulness 
relaxation aims to help eople live with their pain, rather than fighting against it [37]. 
Participants were randomly allocated to a trial arm by drawing from concealed numbers. 
The outcome measures used for pain (Neuropathic Pain Scale) and quality of life 
(NeuroQoL) were validated for neuropathic pain. Previous studies informed a sample size 
calculation, however the target was not achieved allowing the possibility of type II error. 
Further to this, analysis was not carried out to investigate differences between study 
arms for participant characteristics at baseline and there was no mention of blinding of 
outcome assessors thus detection bias was a potential issue. There was minimal loss to 
follow up but management of missing data was not described.
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Overall, these studies defined their participant eligibility criteria, used appropriate 
outcome measures for pain and quality of life in persistent pain states, and described the 
interventions clearly. They were all of small sample size, experiencing difficulty recruiting 
participants, or retaining participants within the studies. In half the studies appropriate 
steps had been taken to blind researchers, but for the interventions studied it was 
difficult to achieve true blinding of participants. The main concerns with all the identified 
studies were high attrition rates and the lack of clear intention to treat analysis; this 
allows results to be inflated in favour of the interventions. 
Results of individual studies
Detailed results can be found in Table 2 – Synopsis of selected studies. Here, we 
give a narrative account and include raw mean scores, as they are important and can be 
suggestive of effect size in some of these low-N studies. 
Ahn et al. [33] used the Short Form-36 (SF36) questionnaire that includes a bodily 
pain subscale. There were no differences between the Tai Chi arm and the control arm at 
baseline; in contrast, the Tai Chi arm’s bodily pain was significantly different to the 
control arm’s after the 12 week intervention period (p = 0.009). In the Tai Chi arm, mean 
bodily pain improved from 67.50 (SD 28.50) to 79.37 (19.98), while the control arm mean 
worsened from 71.71 (19.91) to 60.36 (24.49). No adverse effects were noted for 
participation in the Tai Chi arm.
Dixit et al. [34] demonstrated a statistical difference in the pain subscale of the 
NeuroQoL in favour of the aerobic exercise arm (p=0.03), although this appears to be due 
to the control arm worsening in their pain rating mean 1.65 (SD1.75) to 1.73 (1.69), 
whereas the intervention arm demonstrated minimal change 1.60 (1.76) to 1.61 (1.29),
Otis et al. [35] used the West Haven Yale Multi-dimensional Pain Inventory, which 
includes pain severity and pain interference subscales. Hierarchical Linear Modelling was 
used to account for repeated measures with analysis only reported for variation between 
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baseline and 4-month follow-up.  Examination of regression coefficients showed that 
participants in the CBT arm improved with treatment, whereas those in the control arm 
did not. In terms of raw scores, the CBT arm improved in pain severity from baseline 
mean 3.92 (SD 1.35) to 2.79 (1.21) at the end of treatment phase, which was maintained 
at four-month follow up, 2.83 (1.27). The control arm pain severity showed less change, 
being 3.75 (0.85) at baseline, 3.83 (0.67) at end of treatment and 3.71 (0.91) at four-
month follow up. Similarly, mean pain interference improved in the CBT arm from 3.80
(1.62) to 2.29 (1.71) at the end of treatment phase and decreased slightly to 2.45 (1.54) at 
follow up. The pain interference scores for the control arm were unchanged, from 3.32
(1.94) to 3.30 (1.70) at follow up The authors calculated change scores (baseline to follow 
up) for both of these variables, and confirmed that the change scores were significantly 
different in both groups (both p < 0.05). 
Teixeira [36] proposed mindfulness relaxation would lead to decreased pain. The 
results demonstrated no statistically significant differences in pain between intervention 
and control arms. Numbers in this study were low (N = 10 in each group), resulting in low 
statistical power to detect a significant difference. Thus, it would be productive to 
examine raw mean scores to understand the data better. However, pre-treatment mean 
scores were not reported in this study, so this was not possible. 
Three studies included outcome measures of quality of life. Ahn et al. [33]
demonstrated significant improvements in three SF36 subscales for the intervention arm 
compared to the control arm at follow up: physical role, emotional role and social 
function (all p≤0.006). Dixit et al. [34] found the NeuroQOL total score significantly
improved in the intervention arm,  compared to a slight decrease in the control arm 
(p<0.001). Teixeria [36] also used the NeuroQOL but found no significant change 
following the intervention.
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Synthesis of results
The effects of physical activity on pain are inconclusive in the studies included,
whilst there were significant improvements in pain following Tai Chi, the impact of 
aerobic exercise appears to be due to pain worsening in the control arm, rather than 
improving in the intervention arm. Physical activity appears to improve measures of 
physical, social and emotional life quality. There appeared to be barriers to recruitment 
and retention in the studies of physical activity, which are particularly of relevance given 
the lifestyle factors that can contribute to the development of Type 2 diabetes. CBT 
appeared to benefit participants, improving both pain and pain interference, but 
participants dropped out early in the course. CBT appeared to benefit participants, 
improving both pain and pain interference. However, caution needs to be used when 
considering the clinical and scientific importance of these findings due to the high 
participant attrition rate within this study that may introduce sources of bias.
Discussion
This systematic review aimed to examine the evidence for physical activity and 
psychological coping strategies in the management of PDN. Only two studies of physical 
activity and two studies of psychological coping were identified. The literature was small, 
heterogeneous and with persistent methodological limitations. Physical activity appeared 
to improve overall physical and mental wellbeing, but the impact on pain experience was 
inconclusive in the two studies. In the one study that recorded adverse effects [33], none 
were noted beyond transient pain increases or hypoglycaemia. Mindfulness relaxation did 
not have a significant effect on pain or quality of life. CBT was reported to improve both 
pain and pain interference, but in a small pilot study where risk of bias may have been 
raised due to high participant dropout.
The studies that investigated a form of physical activity, Ahn et al. [33]
demonstrated Tai Chi improved the SF36 bodily pain domain, yet Dixit et al. [34]
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demonstrated the aerobic exercise arm remained unchanged. It should be noted that the 
data in Dixit et al. [34] showed improvement in quality of life, despite the pain scores 
remaining unchanged. The improvement in quality of life is mirrored by Ahn et al. [33] -
there is some improvement in life quality with physical activity. It maybe the interplay 
between physical health, mental health and pain is sufficiently complex that certainty of 
the effect of these interventions on the persons’ pain experience cannot be established 
from these two studies.
Significant limitations of the research selected were low rates of recruitment and 
retention within physical activity studies. The attrition rates (23-33%) do not reflect other 
studies of pain rehabilitation, for instance a Cochrane review of exercise for fibromyalgia 
syndrome found attrition rates between 0-18% [38]. While fibromyalgia has a range of 
symptoms, it does not affect multiple bodily systems in the same manner as diabetes. A 
recent systematic review [39] of exercise in diabetes that included 12 studies found 
attrition rates 0-18% in 10 of their included trials. The high rates of attrition found in this 
review, possibly reflect the difficulties of increasing and maintaining physical activity,
experienced by people with diabetes and pain. Strategies for health behaviour change 
would need to be considered in the development of any clinical service.
The psychological coping interventions studied were CBT [35] and Mindfulness 
relaxation therapy [36]. There is insufficient evidence to make recommendations on 
psychological therapies for PDN from these studies. While the results from the pilot study 
carried out by Otis et al [35] appear encouraging, the high dropout rate limits the quality 
and validity of the findings. As highlighted previously patients have varying explanations 
for neuropathic pain, and varying levels of acceptance that psychological processes are 
relevant to their pain experiences [26]. Guidance from the British Pain Society stresses 
that engagement with multidisciplinary pain programmes cannot be coerced [20] and 
assessment must be made of the person’s readiness to adopt alternative physical and 
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psychological behaviours. Otis et al. [38] note that dropout occurred by session three of 
eleven, we suggest a possible explanation that participants were not sufficiently engaged 
in CBT to stay the course. An important consideration in future trials of non-
pharmacological interventions for PDN is to explore reasons for refusal to participate and 
drop out.  This would help to inform the clinical acceptability of such interventions to a 
wider range of people with PDN.
This review has raised an important question: why were so few research studies 
found investigating non-pharmacological management strategies for PDN? The 
prevalence of PDN is increasing; it impacts on day-to-day functions; it is distressing; 
patients want their walking ability to be improved [22]; the available analgesics are not 
sufficient to ameliorate this impact and are costly - yet there is a paucity of research 
available. We chose to limit the search to PDN specifically, rather than neuropathic pain 
generally due to the co-morbidities that are present in the diabetic population. We used 
broad search terms for physical activity and psychological coping to ensure all potential 
studies using these interventions were included. We specified controlled methodologies, 
which led to five studies being excluded from the final selection, but choose to look for 
the most robust level of evidence for the effectiveness of these interventions. We 
contend that this r view highlights an area of persistent pain that is underrepresented in 
pain rehabilitation research and potentially a population who are underrepresented in 
clinical rehabilitation services. 
Further research
Further high quality research is required to understand whether physical activity 
and/or psychological coping interventions are of benefit and acceptable to the population 
with PDN. Such research must utilise outcome measures sensitive to change in 
neuropathic pain, and include measures of functional ability, specifically measures of 
mobility, as well as pain experience and pain related quality of life [40].
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Conclusions
A cornerstone of pain management programmes aims to assist people to improve 
their physical capacity. The two studies investigating physical activity contain significant 
methodological bias, most notably high levels of participants lost to follow up.
The other cornerstone of pain management is psychological coping, yet the paucity 
of the studies retrieved does not allow firm conclusions to be made on the best 
psychological strategies to help people to cope with their persistent pain.
The lack of research found in this review highlights the need for further high quality 
non-pharmacological research and improved management of this painful, distressing and 
costly condition.
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Table 1 – Search strategy
1. PAIN explode all trees (MeSH) 
2. DIABETES explode all trees (MeSH) 
3. Neuropath* or Polyneuropath* 
4. 1 AND 2 AND 3 
5. PSYCHOTHERAPY explode tree1 (MeSH) 
6. COGNITIVE THERAPY single term (MeSH) 
7. BEHAVIOUR THERAPY explode tree 1 (MeSH) 
8. BIOFEEDBACK (PSYCHOLOGY) single term (MeSH) 
9. ((behaviour* next therapy) or (behaviour* next therapies)) 
10. ((cognitive next therapy) or (cognitive next therapies)) 
11. (relax* near technique*) 
12. ((relax* near therapy) or (relax* near therapies)) 
13. meditat* 
14. psychotherap* 
15. (psychological next treatment) 
16. ((psychological next therapy) or (psychological next therapies)) 
17. (group next therapy) 
18. (self-regulation next training) 
19. (coping next skill*) 
20. (pain-related next thought*) 
21. (behavior* near rehabilitat*) 
22. (psychoeducation* next group) 
23. (psychoeducation* next groups) 
24. (psycho-education* next group) 
25. (psycho-education* next groups) 
26. (mind and (body next relaxation next technique*)) 
27. MIND-BODY AND RELAXATION TECHNIQUES explode tree 1 (MeSH) 
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28. Mindfulness 
29. Mindfulness-based stress reduction or MBSR 
30. Mindfulness-based cognitive therapy or MBCT 
31. Acceptance-based or acceptance based 
32. Acceptance and commitment 
33. 5 OR 6 through 32
34. ((exercise* or resistance or strength or flexibility or endurance) near (train* or program*)) 
35. ((resistance or aerobic* or endurance*) near exercise*) 
36. (interval training or sport* or movement therap*) 
37. stretching.mp 
38. (dance therap* or exercise* or “Tai Ji” or “Tai Chi” or “Tai-Ji” or “Tai-Chi” or walking or 
yoga) 
39. graded near (activit* or exercise* or program*) 
40. physical* near (active* or therap* or exercise*)
41. exp kinesiotherapy/ 
42. (nerve or neural) near (glid* or slid*) 
43. (nerve or neural) near (exercise* or therap* or treatment* or mobilization*) 
44. (nerve or neural) near (tension or mechanic* or dynamic*) 
45. 34 OR 35 through 44
46. 5 AND (33 OR 45)
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Table 2 – Synopsis of selected studies1
Authors Ahn et al. [36] Dixit et al. [37] Otis et al. [38] Teixeira [39]
Research objective Physical activity Physical activity Psychological coping Psychological coping
Study design Quasi-experimental 
controlled trial
Single blind, RCT Single blind, RCT Open label, RCT
Participant 
characteristics
Mean age 
(standard 
deviation) 
Gender
Type of DM 
Duration of DM
Duration of PDN 
Location of 
treatment
Intervention (n=20): 66 (6.4) 
years, 12 male, all Type 2, DM 
duration - 12 (8.8) years. PDN 
duration not stated. 
Control (n=19): 62.7 (7.5) 
years, 8 male, all Type 2, DM 
duration - 13 (10) years. PDN 
duration not stated. 
Korean University Hospital 
outpatient clinic.
Intervention (n=40): 54.4 
(1.2) years, 22 male, all Type 2 
DM type, DM duration 
65.5(1.9) months, PDN 
duration not stated.
Control (n=47): 59.4(1.1) 
years, 31 males, all Type 2 
DM, DM duration 82.1(1.6) 
months, PDN duration not 
stated.
Tertiary care centre, India.
Intervention: 62 (11) years, all 
male, all type 2 DM, DM and 
PDN duration not stated. 
Control: 63 (11.6) years, all 
male, all type 2, DM and PDN 
duration not stated. 
US veterans medical centre.
All participants (n=20): 74 
(10.8) years, 5 male, all type 
2, DM duration - 12.6 (9.4) 
years, PDN duration – 7.7 
(6.6) years. Community 
medical practice and 
retirement communities, USA.
Sample size n=59 n=87 n=19 n=22
PDN diagnostic 
criteria
10g monofilament 
assessment, NTSS
Physician assessment.
Other causes for neuropathy 
excluded
Medical records screened for 
primary complaint of 
neuropathic pain in hands or 
feet 
Self-referred, no medical 
screening
Intervention Tai Chi (40 minutes Tai Chi 
movement, with 15 minutes 
Qigong warm up and cool 
down), 2x1 hour per week, 12 
weeks, plus routine education 
on diabetes management
Aerobic treadmill exercise at 
40-60% of HRR, 5-6 days per 
week, accumulating 150-360 
mins/week exercise, at RPE 6-
20. 8 weeks.
Advice on foot care and 
hypoglycaemia
Individual CBT, 1-hour 
session, x11 sessions. Content 
included: cycle of pain, pain 
mechanisms, relaxation, 
identification and challenge 
negative thoughts, pacing, 
sleep strategies.  
Mindfulness relaxation. 1 
hour session then audio CD 
for home practice.
2
3
4
Authors Ahn et al. [36] Dixit et al. [37] Otis et al. [38] Teixeira [39]
Control arm Routine education on 
diabetes management
Weekly physician 
appointments with diet and 
foot care advice
Treatment as usual, offered 
CBT after completion of 4 
month follow up.
Nutritional advice (1hour) and 
asked to keep a food diary for 
4 weeks
Outcomes SF36 (Korean) NeuroQoL WHYMPI NPS
NeuroQoL
Main findings SF36: Bodily pain subscale Tai 
Chi arm: mean 67.5(SD28.5) 
to 79.37(19.98), Control arm: 
71.71 (19.9) to 60.36(24.49) 
(p=0.009). 
Quality of life
SF36 subscales: physical 
function Tai Chi arm 
improved mean difference 
4.75(16.58), control -
5.78(11.69), p=0.028. Role 
physical Tai Chi 17.25(28.64), 
control -4.02(14.20), p=0.006. 
Role emotional Tai Chi 
17.5(24.78), control -
7.36(20.73), p=0.002. Social 
function Tai Chi 10.89(30.29), 
control -18.28(18.85), 
p=0.001.
All other SF36 subscales were 
NeuroQOL Pain subscale 
exercise arm: 1.6(1.76) (CI 
2.12 – 1.08) to 1.61(1.29) (CI 
2.08 – 1.14), control arm: 
1.65(1.75) (CI 2.17 – 1.14) to 
1.73(1.69) (CI 2.28 – 1.18), 
p=0.03.
Quality of life
NeuroQOL total score 
improved in exercise arm:
32.85(1.32) (CI 33.28 – 32.42) 
to 24.14(1.12) (CI 24.82 – 24), 
control arm: 33.55(1.37) (CI 
33.95 – 33.15) to 34.16(1.37) 
(CI 34.61 – 33.71), p<0.001.
HLM: Pain severity CBT group 
decreased B=-0.54, (CI -0.9 to 
-0.99). Control arm were 
unchanged (B=0.00).
Pain interference slope B=-
0.77 (CI -0.24 to -1.30), 
compared to control arm B=-
0.09 (CI 0.3 to -0.48)
Between arm pre-post 
(4/12): pain severity 
decreased mean 1.08 (0.79), 
Control arm unchanged, mean
0(0.51), p<0.1.
Pain interference declined 
CBT mean 1.35 (SD 1.22), 
control arm increased mean 
0.22 (SD 0.73), p<0.5.
Hypothesis (Mindfulness 
leads to decreased pain): no 
significant difference in pain 
intensity or pain 
unpleasantness.
Hypothesis (Mindfulness 
leads to quality of life 
improvement): no significant 
difference in overall, 
symptom related or pain 
quality of life. 
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not significantly different 
p>0.1.
Adverse 
effects/events
Reported: None noted Not reported Not reported Not reported
CI – confidence interval, CBT – Cognitive behavioural therapy, DM – Diabetes mellitus, HLM – Hierarchical linear modelling, HRR – Heart rate reserve, 
NPS - Neuropathic pain scale, NTSS - Neuropathy total symptom score, PDN – Painful diabetic neuropathy, RCT – randomised controlled trial, RPE –
rate of perceived exertion, SD – Standard deviation, WHYMPI - West Haven Yale Multidimensional Pain Inventory
5
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Table 3 – Cochrane risk of bias summary6
Random 
sequence 
allocation
Allocation 
concealment
Blinding of 
participants 
and 
personnel
Blinding of 
outcome 
assessment
Incomplete 
outcome 
data
Selective 
reporting
Other bias
Ahn et al. [36] + - - ? - + ?
Dixit et al. [37] + - - + - + -
Otis et al. [38] + - ? ? - ? ?
Teixeira [39] + ? - ? ? + ?
- The method described contains a high risk of bias, + The method described contains a low risk of bias,? The risk of bias 
cannot be ascertained from the described method, Higgins et al 2011
7
8
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Figure A – Study selection8
10
12
14
16
18
20
22
24
26
28
30
32
34
36
38
40
Articles generated by search strategy (n=1306, after removal of duplicates)
Abstracts reviewed for relevance (n=179)
Articles excluded at title review (n=1127)
Articles excluded at abstract review (n=156) 
Full text articles relevant to 
physical activity (n=18)
Full text articles relevant to 
psychological therapy (n=5)
Search strategy developed and applied to Medline, AMED, EMBASE, CINHAL, 
SportsDISCUS, PsychINFO, Cochrane, PEDro, BioMed and Web of Science
Full text articles excluded due to: 
no pain outcome measure (n=11),
non-controlled design (n=4), PDN 
an exclusion criteria (n=1), 
language (n=1)
Physical activity final articles (n=2) Psychological coping final articles, (n=2)
Full text articles excluded due to: no 
pain outcome measure (n=2), non-
controlled design (n=1)
Search repeated for 2013/14. Two further articles found for physical activity, one 
excluded as subgroup PDN data unavailable
